SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-014724
Filing Date
2022-05-23
Accepted
2022-05-23 12:07:46
Documents
55
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 763388
2 ex31-1.htm EX-31.1 12663
3 ex31-2.htm EX-31.2 11146
4 ex32-1.htm EX-32.1 6344
  Complete submission text file 0001493152-22-014724.txt   3799496

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE tsoi-20220331.xsd EX-101.SCH 28674
6 XBRL CALCULATION FILE tsoi-20220331_cal.xml EX-101.CAL 52784
7 XBRL DEFINITION FILE tsoi-20220331_def.xml EX-101.DEF 109068
8 XBRL LABEL FILE tsoi-20220331_lab.xml EX-101.LAB 266523
9 XBRL PRESENTATION FILE tsoi-20220331_pre.xml EX-101.PRE 212135
49 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 429775
Mailing Address 701 WILD ROSE LANE ELK CITY ID 83525
Business Address 701 WILD ROSE LANE ELK CITY ID 83525 (760) 295-7208
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. (Filer) CIK: 0001419051 (see all company filings)

IRS No.: 451226465 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54554 | Film No.: 22950450
SIC: 3841 Surgical & Medical Instruments & Apparatus